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2.
IlIRODUCTIQh
The use of the long-acting insulins now enable most diabetics 
to live comfortably on one injection daily. The desire has 
not lessened, however, for an oral preparation which could 
obviate the troublesome injections. Attempts to produce an 
insulin preparation which could be absorbed from the bowel 
have been unsuccessful and seem almost hopeless. Attention 
has therefore been directed to other drugs which might have 
a beneficial effect.
Because aneurin, riboflavin and nicotinamide are essen­
tial for carbohydrate metabolism, numerous investigations 
were carried out on these vitamins. Results were so conflic­
ting that it was not until recently that the position grad­
ually became clearer. Since opinions are still not unanimous, 
however, it seemed that further investigations would not be 
without value.
The fasting blood-sugar level of each individual is 
stated to be remarkably constant (Lichtwitz}. Diabetics, 
as one would expect, show a greater variation. It is obviously 
necessary, however, when investigating the blood-sugar 
changes produced by injections of vitamins, that control 
investigations should also be carried out simultaneously on 
subjects who have not been given these injections.
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For reasons of convenience, a modified Folin and ^u’s 
procedure was used to estimate the blood-sugar levels. This 
method gives results which are ten to thirty mg.% higher 
than the true figures, due to the presence in the filtrate 
of reducing substances such as thioneine and glutathione. 
The difference between this and the true figure is suffic­
iently constant to make the readings quite satisfactory for 
showing changes in the blood-sugar levels.
Oxalated and fluorized venous blood was used. Although 
this usually contains five mg.% less glucose than arterial 
blood, it shows the same changes in blood-sugar levels as 
the arterial blood.
The sugar estimations were usually carried out about 
six hours after taking the blood specimens. Since the 
glucose level of correctly fluorized blood remains constant 
for seven days (Van der rfalle and Hoeridin) no change could 
have occurred in this short period.
The method used was as follows; 0.1 ml. of oxalated 
and fluorized blood was added to 3.5 ml. distilled water. 
0.2 ml. each of 10% sodium tungstate and of 2/3 IT. sul­
phuric acid was added. These accurately neutralised each 
other to form tungstic acid which precipitated the blood 
proteins. The mixture was filtered after standing for 
ten minutes.
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Two ml. of the filtrate and 2 ml.ofcthe alkaline copper 
solution in a -Folin and tfu'e tube were placed in a boiling 
water bath for six minutes. The copper sulphate was reduced 
to cuprous oxide in amounts proportional to the concentration 
of glucose. The addition of 2 ml. of the sodium phospho- 
molybdate solution dissolved the cuprous oxide to produce 
an intensely blue molybdenum salt.
The colour developed was not rigidly proportional to 
the blood-sugar concentration when the difference between 
the concentrations was very marked. Two standard solutions 
were therefore prepared to ensure accurate results, one with 
100 mg. glucose per cent, and one with twice that amount. 
These were used to produce the standard blue solutions which 
were compared in the colorimeter with the unknown solutions.
One has noticed in some previous papers on similar 
investigations, that some of the biochemical results seemed 
to be remarkably inaccurate. Let us take one of these papers 
as an example (Hodieek) .
In the second paragraph of the experimental section, 
the writer states: "The fasting levels of blood-sugar of 
normals and diabetics without any treatment do not change 
appreciably during such a short experimental period."
Table 1 of that article gives figures for the changes 
in the blood-sugar levels in diabetics after the intravenous
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injection of 2 mg. of aneurin.
The fasting sugar of Patient 1 dropped from 318 to
El8 mg.% in one hour.
That of Patient 5 dropped from 163 to 83 mg.% in one
hour, and was . 2QD mg.% an hour later.
The blood-sugar of patient 6 rose by 67 mg.% in 3D 
minutes.
patient 8*s sugar level dropped from 144 to 76 mg.% 
in thirty minutes.
The fasting sugar of Patient 13 rose by 157 mg.% 
in one hour.
That of Patient 18 rose from 106 at 30 minutes to 
E45 mg.% at 60 minutes.
Kodicek's statistical analysis of that table shows that 
aneurin does not affect the fasting blood-sugar values of 
diabetics. One must presume that the writer was satisfied 
with a considerable degree of inaccuracy from the bio­
chemists, as such relatively enormous changes could not 
really occur in diabetics in the absence of any cause.
The present investigator therefore decided to carry 
out the biochemical work himself, i/he never a difference of 
more than ten mg.% was found between two consecutive spe­
cimens, the estimations were repeated to verify this change.
On numerous occasions during the course of the investi­
gation, the blood-sugar estimation was repeated five times
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on the same blood specimen to determine the accuracy of the 
investigator's technique. Table I shows ten typical sets of 
readings.
TABLE I
Blood-Sugar Yalues Obtained On 
Blood Specimens, Mg.%
Same
Mean
Standard
Deviation
1 76 86 77 83 79 80 4.2
B 121 132 130 110 112 121 10.0
3 335 355 345 363 359 351 11.4
4 232 243 253 263 246 247 11.6
5 144 138 141 148 139 142 4.1
6 82 78 76.5 87. 5 73 79 5.6
7 108 128 114 128 122 120 8.9
8 68 63 58 68 61 64 5.0
9 86 86 85 85 88 86 1.2
10 234 239 217 233 230 231 8.3
Average Standard Deviation 7.0
The standard deviation of these readings seemed to be
a suitable way of comparing them with those in the follow-
ing tables. It was noticeable that the standard deviation
increased considerably as the blood-sugar levels reached 
diabetic figures. It is evident from this table that an 
average standard deviation of 7.0 can be obtained with
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blood-sugar levels which are quite constant.
To determine how much of the error of estimation was 
due to inaccuracies in reading the colorimeter, the readings 
on various occasions were repeated five times on the same 
blue solution, the colorimeter scale being moved after each 
reading. Table II shows that this error becomes important 
with high sugar levels.
TABLE III
Figures to Indicate Error in Heading 
Colorimeter. Mean.
Standard
Deviation
1 240 236 232 234 235 235 3.0
2 208 200 200 202 204 203 3.3
3 208 212 204 210 209 209 3.0
4 180 182 180 182 183 181 1.4
5 235 232 230 236 231 233 2.6
6 210 208 210 220 216 213 5.0
7 61 61 62 62 62 62 0.7
8 102 101 102 101 103 102 0.9
9 88 86 89 88 87 88 1.2
10 96 98 . 97 99 97 97 1.2
Average Standard Deviation 2.2
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CONTROL INVESTIGATIONS•
THE COUTBOL IUVESTIGATIOHS 
In the investigation about to be described, the following 
procedure was used; The patient had been fasting for approx­
imately fifteen hours. The first blood sample was taken, 
and the intravenous injection iof the vitamin preparation 
immediately given. Further blood samples were removed after 
thirty minutes, one hour, two and three hours.
This was carried out on ten non-diabetic patients, 
omitting the vitamin injection, as a control investigation, 
fable III shows the results obtained.
TABLE III
patient's 
Initials.
Blood-Sugar Concentration Mg.% 
Time in Hours After Investigations 
Commenced.
0 i 1 2 3
Mean
Standard
Deviation
W.C. 99 90 84 76 91 88 8.6
D.B. 118 113 110 116 113 114 3.1
J.M. 98 88 81 82 83 86 7.0
J.F • 120 109 116 112 101 112 7.0
G.R. 109 92 94 95 108 100 8.2
I.M. 92 97 84 80.4 93 89 6.9
R.D. 120 114 111 115 114 115 . 3.3
M.B. 90 103 101 109 106 102 7.3
M. D • 97 92 90 91 98 94
***to
H.E. 84 86 90 82 84 86 2.5
Average standard Deviation Ol • CD
11.
____
The standard deviation seemed to be quite a convenient 
method of comparing the controls wit hi. the other subjects, 
as it gave a measure of the variation in the blood-sugar 
values occurring during the period of three hours. The average 
standard deviation of 5.8 showed that on the whole the fast­
ing blood-sugar levels of the controls remained fairly 
constant.
The results of this control investigation, with comments, 
are given in graphical form in the following pages.
aged 3-l, had an enlarged liver and spleen, with ascites, 
oedema and alouminuria. his skin was pigmented, but there was
no glycosuria, histological examination after death confirmed 
the diagnosis of haemochromatosis, with cirrhosis of the liver, 
The cirrhotic liver may have been responsible for the unstable 
fasting blood-sugar level shown here, which was confirmed by 
repeating the estimations.
no
!L
D.B.,aged 45, had a bronchogenic carcinoma with secondary
subcutaneous nodules.
lor
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J.M.,aged 63, had a severe congestive heart failure with
oedema of the legs and enlargement of the liver.
13.
TT
110
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J.F.,aged 51, had a chronic sinusitis and mild atypical
pneumonia.
to©
G.E.,aged 28, showed signs of early disseminated sclerosis.
14.
90
I.M.,aged 20, had a unilateral bronchiectasis of two years’
duration.
I o
?..D.,aged 54, showed slight signs of bronchiectasis on 
screening the chest, but turned out to be quite healthy.
15.
loo
aged 65, had the symptoms of a small coronary thrombosis
I'j I [ 1
X* H c\\/t3  a fc n  ttaifc CfTnvM^sJj . 3
IS.D., aged 34, was a very obese woman who had occasionally
shown a slight glycosuria.
ii&tttoy Ga>r>vv«x-<
H.H.,aged 36, was a naematemesis case with a long history
o± peptic ulcer symptoms.
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Tiie results obtained from the four diabetics used as 
controls are given in Table IV. This is followed by the same 
results given in graph form. The diabetics, in addition to 
having been fasting for about fifteen hours, had received no 
insulin for at least 26 hours.
TABLE IV
Patient1 s
Initials.
Blood-Sugar Concentration Mg.% 
Time in Hours After Investigation 
Commenced.
0 b 1 2 3
Mean Standard
Deviation
E.l. 281 288 284 272 275 280 6.2
E.M. 260 258 268 258 245 258
03CO
M.S. 253 235 230 215 210 229 17.1
V.C. 260 253 253 241 245 250 7.5
Average Standard Deviation 10.7
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i
'fCX/Q/gv^ty UX
COVYVW'*-''
K .W.,aged 25, had been a diabetic for four years, fairly well 
controlled on a 16 line diet with 30 units S.I. and 15 units 
P.Z.I. daily.
31*7 0
X  H  O V W  t o t  CAm v  * ALvO<| , 3
H.I2. ,aged 64, had been treated by diet for glycosuria for 
two years.
IB.
u*
i H CAXnfO tjt C «7V *V ln i\tw C >et . 3
Li.G. , aged 51, was getting 2C units S.I. daily for her diabetes 
of four years’ duration.
19.
fCj pJLfc'xtvJU>
V.G.,aged 42, had "been getting a small dose of P. 1,1. daily 
ior her diabetes of twelve years’ duration.
/2rfC£L
20.
TEE CAiiBOEYDKATiS METABOLISM
-* LJ"x -J r;r ;; !a:
21.
THE OAKBOHYDKATE LIE TAB OL ISM.
This might now he a suitable stage at which to describe 
briefly the processes occurring during carbohydrate metabolism, 
and to discuss why the B vitamins might aid this metabolism 
in diabetes mellitus.
The digestive .juicee of the stomach, small bowel and 
pancreas break up the carbohydrate food material into the 
three monosaccharides - glucose, galactose and fructose.
These are absorbed,mainly in the small bowel, by two methods:
(1) Phosphorylation - the coupling of the monosaccharide 
with phosphoric acid to produce a hexose-phosphate. This 
occurs as soon as the monosaccharide has diffused into the 
intestinal wall. (This process is depressed by phloridzin.
Since reabsorption of glucose from the renal tubules occurs 
by phosphorylation, phloridzin thus produces a renal gly­
cosuria ).
(2) Diffusion alone across the mucous membrane into the 
blood stream. This takes place only to a small extent.
The fructose and galactose are converted to glucose and 
glyc ogen in the liver. The glucose is disposed of in three 
main ways:
(a) Transformation into fat. There iE increasing evi­
dence that more glucose is stored as fatty acids than as 
glycogen. It is thought probable that the conversion of 
glucose to fatty acids takes place mainly, if not entirely,
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via hexose-phosphates and pyruvic acid, hut there is not 
yet any definite evidence of this (Young). It is known that 
aneurin is necessary for this process, and probably also 
insulin.
(b) Conversion to liver and muscle glycogen is the 
second method; and finally
(c) Oxidation.
Role of Insulin. The phosphorylation of glucose through the 
action of an enzyme called hexokinase may be demonstrated 
diagramatically as follows:
GLUCOSE + ADEHOSIIIE TRIPHOSPHORIC ACID Hexokinase
GLUC 0 SE-6- PHO SPH ATE t ADEN OS HIE DIPHOSPhORIC ACID. 
This process may be essential for the passage of glucose 
through the membranes of cells. The metabolism of glucose 
within the cell may be impossible without it.
Certain freshly prepared anterior-pituitary extracts 
can depress this action of hexokinase in-vitro; and this 
depressive action can be prevented by the in-vitro addition 
of insulin to the system. The depressive action can be pro­
longed by a secretion of the adrenal cortex.
That the main action of insulin in-vivo is this release 
of hexokinase from pituitary inhibition is not certain, 
however. Insulin exerts, for instance, a greatly exaggerated 
hypoglycaemic action in hypophysectomised animals who have 
therefore no hexokinase inhibitor.
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A recent and so far unconfirmed report shows that in­
sulin promotes the formation of glycogen from glucose-1- 
phosphate in liver slices under certain conditions. Hexo­
kinase does not appear to take any part in this procedure.
Although insulin greatly facilitates the transformation 
of glucose to glycogen, this can proceed at a lessened rate 
in the total absence of insulin. The site of action is 
probably higher than the pyruvic acid stage in carbohydrate 
metabolism. It promotes the formation of pyruvic acid, and 
thereby increases the rate of oxidation of carbohydrate. 
Insulin may also facilitate the formation of fat from car­
bohydrate .
The foie of insulin in glycogen formation may be sum­
marised diagramatically as follows:
GLUCOSE + A3M10SIUE TRIPHOSPHATE
Hexokinase.. Action inhibited by anterior pituitary 
extract. This inhibitory action pre­
vented by HT SUL III.
GLUCOSE-6-PHOSPHATE + ADEHOSHTE DIPHOSPHATE
Phosphoglucomutase and Magnesium
GLUCOSE-1-PHOSPHATE
i Phosphorylaee and IHSULIH.
GLYCOGEI!
Role of Vitamin 3 Complex. This will be discussed separately 
in later parts of the paper. The following figure (adapted
from yohl’s Dietotherapy, 1945, p 57) shows the relative
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stages in the carbohydrate metabolism at which insulin and the B 
vitamins act. The substances indicated alongside the arrows 
are necessary for the reactions to occur in both directions.
GLYCOGEN
Insulin Phosphorylase
GLUCOSE-1-PHOSPHATE
Magnesium phosphogluc omutas e
GLUCOSE--------- -> GLUC0SE-6-PH0SPEATE
He^oAinase
Insulin FHUCTOSE-li6-PHOSPHATE
3 GLYCHKALDEEYDE PHOSPHATE
Phosphorus Nicotinic Acid
1:3 PHOSPHOGLYCEBIC ACIDU
PHOSPHOPYBUVIC 
t ACID 
OXALACETIC ACID
'N
Aneurin
3 PHOSPHOGLYCEBIC ACID 
Magnesium
PHOSPHOPYBUVIC ACID
PYKOTIC acid
Nicotinic ACID 
Belative oxygen lack
Phosphorus
Magnesium
Aneurin 
Blboflavin 
Nicotinic Acid
LACTIC ACID 
(Converted back 
to glycogen in 
the liver)
co2 - e 2o
It can thus be seen that there is no point known at 
present at which insulin and any of the B complex vitamins 
act together. There is therefore no theoretical reason why 
a deficiency of insulin could be remedied by an increased 
dosage of any or all of the vitamin B complex.
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WHY THE VITAMIN B COMPLEX MAY BE BENEFICIAL IN 
DIABETES MELLITUS
M Y  THE VITAMIN B COMPILE MAY BE BENEFICIAL IN 
DIABETES MELLITUS
There have "been many conjectures made on this subject, 
and some of them could not be taken too seriously. The more 
likely and interesting ones might briefly be discussed here.
(1) The vitamins may help to control the nutrition of 
the p  cells of the islets of Langerhans. There is no evidence 
at present that this is correct. In addition, the B complex 
is claimed to have a beneficial effect on depancreatized 
animals, who presumably have no remaining islet tissue.
(2) The abnormal carbohydrate metabolism when insulin 
is deficient may necessitate an increased intake of the B 
vitamins, or might interfere with their utilization.
(3) An inadequate intake of B complex may occur in many 
diabetics due to the substitution of foods poor in the 
complex for prescribed foods with a richer content.
(4) Severe arteriosclerosis may require a higher con­
centration of aneurin in the blood, to provide sufficient 
vitamin to the nerves, than in subjects with normal arteries 
(Baide). This seems a very unlimely theory. The arterioles 
would probably nave to be so narrowed that gangrene had set 
in before the vitamin supply to the nerves was impaired.
The capillaries, unaffected by the arteriosclerosis, would 
still allow the vitamins to diffuse out quite normally.
(5) The polyuria in untreated and poorly treated dia­
betics may cause increased excretion of the vitamins.
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(6 ) There might he a stage in the carbohydrate metabolism 
at which both insulin and any of the B vitamins acted, so 
that a deficiency of insulin could be remedied by an in­
crease in the necessary vitamin. Thus, the B vitamins might 
exert an action similar to insulin in preventing the anterior 
pituitary inhibition of hexokinase activity and the resulting 
disruption of carbohydrate metabolism. There is, unfortun­
ately, no evidence that this occurs, and careful examination 
of the stages of carbohydrate metabolism known at present 
does not show any point at which the two groups act together.
(7) They might raise the renal threshold for glucose 
and thus diminish the glycosuria. There has never been any 
reliable indication that this occurs; and even with the 
glycosuria diminished, the abnormal carbohydrate metabolism 
would continue, which is much more important in the severe 
diabetic.
At present, therefore, the two most likely theories 
seem to be:-
(a) The diminished vitamin B content of the diet, and 
the excessive excretion of the vitamins may cause the B 
vitamin content of the diabetic’s body to be below normal.
(b) The diabetic may contain normal amounts of the
B vitamins, but the abnormal metabolism may require larger 
quantities than usual fof these vitamins.
Reference. llaide, M. 1939. Am. J.II. Sc. 197, 766.
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VITAMIN 3X AND BLOOD SUGAR LEVELS
VITAMIN B3. AND BLOOD-SUGAR LEVELS
The effect of an intravenous injection of aneurin hydro­
chloride was determined on eighteen non-diabetic patients. 
Fifteen of them were given 25 mg.of the vitamin, and three 
received 100 mg. The doses are indicated on the individual 
graphs, which follow Table V summarising the results of this 
part of the investigation. The average standard deviation of 
5.2 indicates that aneurin does not have any significant effect 
on the fasting blood-sugar concentrations of non-diabetic 
persons.
Six diabetics were also given injections of aneurin.
Table VI, summarising their results, is followed by their 
blood-sugar curves in graph form. The average standard 
deviation of 7.3 suggests that vitamin B^ does not affect 
the fasting sugar levels of diabetics.
Table V
Blood-Sugar Concentration 
Patient*s Time in Hoars .after Investigation kean Standard 
Initials. Commenced. Deviation
0, J l I  JL — 1
E.M. .... 7.9 . 88 82 77 80 81 4.2
L.D. ....76 ._.72 70 73 78 74 3.2
J.H. 72 75 86 78 76 .. _ 77 . .....5,3
E.B. 87 83 94 98 97 _ 92 6.5
H.M. 100 ..97 100 ?8 ...99... ...99.. _ 1, 3. .
J.B. ......9.9. 92 ....96 98 88 95 4.6
J.S. 84 78 72 71 81 .... 77 5.6
W.R. 107 22_ .....91... 109 112 .105... . 6.5
Hi. M • . 119 116 87. 82 84 .......98 ,.. 18.6
T.M. 118 108 112 106 101 109 6.4
.C. 111 119 116 112 .103.. 112 6.1
J.C. 82 86 78 76 81 81 3.9
J .M. 118 114 116 103 101 110 7.9
T.C. 92 99 100 90 87 94 5.7
J.C. 101 104 108 114 118 109 7
W . A • 104 101 101 94 102 100 3.8
W.C. 92 -20 92 82 90 4.7
i*P. __ 100 102 102 102 102 102 0.7
Average Standard Deviation
-70
■X M<nm> a|i>f mXanr(%W\ OlW&W
3.M.,aged 58, had an acute exacerbation of chronic nephritis.
L.D.,aged 45, had rheumatoid arthritis for several years.
**<J T 
AatsA-
70
J.H.,aged 27, had a mild acute rheumatoid arthritis.
xs*^ .-A~h,
McVV/T^ C»U"?»\
S.B., aged o9, vvas a cate of clironic congestive heart failure
of some months' duration.
loe <
€-
H.M..aged 46, had auricular fibrillation with mitral stenosis 
and congestive heart failure.
J.i3.,aged 22, had a mild chronic gastritis.
34.
A  j
J.S.,aged 50, was a syphilitic case with aortic incompetence.
CO £q()ti[lUA j 4-^ • AS" vj. ^
HO
ged 5o, was recovering irom ubarachnoid haemorrhagew , xi
35.
tfxkvmhy ^
M.M.,aged 37, had a cerebral thrombosis with a wash positive 
W.E. The marked fall in blood-sugar was confirmed, but could 
not be attributed definitely to the vitamin injection, as 
cerebral lesions do sometimes disturb the carbohydrate 
metabolism.
toe
dev-r* J^JU/WMWX OkU/€v\ . 3
T.M.,aged 65, had a mild congestive heart failure
m/s/«fS. xs^.Jt.3
.V. C., aged 53, had a slow auricular fibrillation for four 
years.
J.C.,aged 55, had a mild coronary thrombosis.
J.I2. ,aged 54, had a small coronary thrombosis.
XT
T.C.,aged 34, was found to have nothing abnormal
fOO
J.e.,aged 16, nad an acute rheumatic fever.
iXLuCVwx
UTJLO I
t-Vr\M^» wtaftVN^vy yjj^ vy
(*J liivQ"" C o c M l l v m .
2. M0\W> <l|^  (rtI<WVtt^ QU&vs
w.C.,aged o4, had recurring attacks of sciatica for 30 years.
W.A.,aged 31, had recurring attacks of left sciatic pain 
for many years.
J . C . , a g e d  38, had mild attacks of diarrhoea of uncertain origin.
4C.
Table VI
Patient's 
Initials.
Blood-Sugar Concentration Mg> • /?
Standard
Deviation
Time
0
in Hours After Investigat 
Commenced.
* 1 2 3
;ion Mean
W.T. 101 106 119 112 109 109 6.8
E.G. 261 259 251 258 267 259 5.8
J.M. 162 169 176 192 197 179 lS.o
D.B. 196 204 208 208 200 203 5.2
A.L. 123 125 116 120 130 123 5.3
C • M» 156 164 152 156 150 156 5.4
Average Standard Deviation 7.3
W.T.,aged 63, was a mild diabetic receiving ten units S.I. 
twice daily.
irx.o
iw-
SiA+pS
loo
-Tn. -f 14-
S. G., aged 27, had "boon receiving no insulin for her severe 
diabetes of four months1 duration.
a^ jts/m-8
X  Hou-O «Jox*vi-v CJW&/V 3
0 .1 0
0.00
D.P.,aged.35, was an acute diabetic who was not yet on in­
sulin.
42.
l)lcv<lvv\
J.L!.,aged 19, was admitted twenty hours previously in 
hypoglycaemic coma. The insulin still seemed to be having 
some effect when this test was carried out. He was receiv­
ing 5C unite S.I. and 30 units P.S.I. daily for his 
diabetes of three years' duration.
no
A,l..aged 55, was a mild, obese diabetic who did not require 
insulin.
t\\S
i—l
C.;£.,aged 47, had not yet been started on insulin for her 
glycosuria which had been discovered accidentally two 
weeiis previously.
PHABMACOLOGY OF VITAMIU
PHARMACOLOGY OF VITAMIU Bx 
A brief summary of the pharmacology of vitamin might 
be of value, before going on to detail the findings of other 
investigators.on this subject.
This vitamin has been given the names Aneurin in Britain 
and Thiamin in America. Its empirical formula is 
QlgHiglT^OSClg, with the following structure:
•3H - C-KHo.HCl CH.
t i I
Hr*C - C C - CH« - U - C * CHo - CHoOH
3 i ii 2 » x  *
N - CH Cl CK-3
It is a water-soluble vitamin which is rapidly absorbed, 
mainly by diffusion, from the small intestine. Possibly some 
absorption also occurs from the large bowel, where some 
biosynthesis of the vitamin takes place to a varying extent 
in man.
The vitamin is partially destroyed, or its absorption 
impaired in achlorhydria, the alkaline treatment of peptic 
ulcer, in ulcerative colitis and other pathological con­
ditions of the gastro-intestinal tract.
Vitamin B^ is stored only to a small extent in the body. 
The greater part is stored in the muscles. When the body 
is saturated, a large part of the vitamin is metabolised 
and the excess destroyed or excreted, when injected intra­
muscularly, the bulk is excreted within the next three hours.
The intramuscular absorption is considerably delayed by zinc.
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It is unfortunate that measuring the excretion of aneurin 
after large doses have been given is not a reliable method 
of estimating the degree of saturation of the body.
Aneurin is excreted in the urine, and much of it is 
washed out when a diuresis occurs in such conditions as 
untreated or badly treated diabetes mellitus. tfhen used 
therapeutically, it must be given at least once a day to 
maintain an adequate concentration. Appreciable amounts of 
the vitamin are contained in perspiration.
A minimum of 1.35 mg. is required for a normal 3,000 
Calorie diet. More vitamin is required in such physio­
logical states as increased muscular activity, rapid growth, 
pregnancy and lactation. The raised basal metabolic rate in 
hyperthyroidism and infective conditions also increases its 
requirement. A satisfactory diet should therefore contain 
two mg. aneurin daily if possible.
The carbohydrate content of the diet is an important 
factor in determining the daily requirements. The aneurin 
requirement is very small on a diet consisting entirely of 
protein and fat, and animals show signs of vitamin deficiency 
only when carbohydrate is added.
Vitamin is phosphorylised mainly in the liver and 
kidneys by enzymes through the agency of adenosine-triphos­
phate. The coenzyme cocarboxylase is formed. This is the 
coenzyme for the enzyme carboxylase.
47.
AEENOSMS TRIPHOSPHATE 4 VIT-uMIE Bx Phosphorylaee^
ADENYLIC ACID 4 COCARBOZYLASE (VITAMIH B1 PYROPHOSPHATE) 
Carboxylase possibly consists of a protein, cocarbox­
ylase and magnesium. It is the enzyme which causes decar­
boxylation of pyruvic acid to form carbon dioxide and 
acetaldehyde.
CHgCO.COOH Carboxylase CH3CH0 4 CO^ 
Cocarboxylase is also believed to be concerned intthe 
synthesis of carbohydrate from lactic and pyruvic acids, 
in glycogenesis, and in the conversion of fructose to 
glucose in the liver. Aneurin is also necessary for the for­
mation of fat from carbohydrate.
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Conflicting reports have heen published on the effects 
of vitamin on the glucose metabolism of different animals. 
Summaries of the more relevant of these papers will now be 
given.
Demole and Silberschmidt found that the administration 
of 0.1 to 4 mg. vitamin 3p had no effect on the blood-eugar 
level of normal rabbits, nor on the temporary hyperglycaemia 
produced by injecting glucose.
Magyar, on the other hand, found that aneurin given 
with an injection of glucose or galactose increased the 
rate of disappearance of the sugar from the blood of rabbite. 
It had no effect on the fasting blood-sugar, but usually 
intensified the hypoglycaemic action of insulin when in­
jected at the same time. The same intensifying action was 
found with human diabetics. He suggested that vitamin 
assisted the cells of the body to take up sugar from the 
blood. It did not, he believed, increase the pancreatic 
output of insulin.
Liotta suggested that the vitamin seemed to normalise 
the blood-sugar of rabbits and pigeons. It had a hypoglycaemic 
effect after the administration of glucose, and intensified 
the blood-sugar reducing effect of insulin. The vitamin did 
net much influence the fasting blood-sugar.
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Lowering of the blood-sugar with small doses, and hyper- 
glycaemia with larger doses, were the findings of Ortoleva, 
working on rabbits. Loux found that injection of aneurin 
pyrophosphoric ester caused a 20 to 40% decrease in blood- 
sugar after a delay of about seven hours.
Janes and Brady found that aneurin deficiency had no 
definite effect on the blood-sugar levels of normal and 
alloxan-diabetic rats. The liver aneurin content of alloxan- 
diabetic rats was approximately one-third that of the average 
value found in normal animals (Bisceglie).
(xlyeogen was found to be absent from B^-avitaminotic 
rats. Injections of vitamin B^ and glucose brought about 
an accumulation of liver glycogen (Tonutti and rfallraff).
Lowry and hegsted showed evidence that alloxan-diabetic 
rats required less vitamin than normal controls. They 
had no increased tendency to develop signs of aneurin de­
ficiency, and the vitamin’s action was not perceptibly 
impaired. Their study, therefore, did not support the theory 
that diabetic neuritis was due to aneurin deficiency.
Experimental vitamin deficiency did not effect 
carbohydrate tolerance, as judged by glucose tolerance tests, 
in either normal or diabetic rats, unless the degree of 
deficiency was extreme when the giving of aneurin appeared 
to improve carbohydrate tolerance (Styron et al.).
In normal rats, Lepkovsky et al. also found that glucose
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tolerance was Impaired only in the later stages of aneurin 
deficiency.
Inclusion of vitamin in ‘the diet of albino rats, 
who were on diets deficient in various combinations of the 
vitamin B factors, increased the hypoglycaemic response to 
insulin. Variations in the intake of other vitamin B factors 
did not markedly alter the sugar tolerance of the rat (Burke 
and McIntyre).
s/ein had found, contrary to the experience of most 
workers, that rats deprived of the vitamin B complex showed 
a greater hypoglycaemic reaction to insulin than those an­
imals receiving a normal diet.
Harper observed a decrease in the rate of absorption 
of glucose from the intestine of aneurin deficient rats, 
with diminished hepatic glycogenesis and glycogenolysis. 
There was no significant difference in their blood-sugar 
levels.
working with dogs, Chesler et al. found impaired glu­
cose tolerance with both a mild and a severe aneurin de­
ficiency. The post-absorptive blood-sugar level was high,and 
both lactic and pyruvic acids accumulated in the blood.
One or two mg. vitamin B were daily injected subcutan- 
eously for a month inco guineapigs on a normal diet. Blood- 
sugar estimations at intervals of ten days showed a steady
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rise. By the end of thirty days they were 120 to 125% of the 
original values. A- marked reduction occurred in the liver 
glycogen content of these animals. These findings of Morelli 
and D ,Ambrosio obviously contradict those of many other workers 
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ANEURIN IN NORMAL PERSONS AND DIABETICS.
The investigations on human beings have also given just 
as variable results. A summary of many of these papers will 
now be given.
Monauni claimed that intravenous aneurin raised the 
blood-sugar level when subnormal, and lowered it when it 
was elevated. De Lucia and Moreli found that the intravenous 
administration of vitamin reduced the blood-sugar of 
healthy persons, but had irregular results in those with 
liver disturbances. In diabeticE, Ijiri believed that in­
jections of vitamin slightly lowered the blood-sugar.
wiieon also experimented on healthy human subjects, 
however, and observed that the intravenous injection of ten 
mg. aneurin had no effect on the fasting blood-sugar level. 
The action on the fasting blood-sugar of ten units soluble 
insulin subcutaneouely was intensified by the intravenous 
injection of twenty mg. vitamin B-j_. The blood-sugar reached 
a lower level, and took longer to rise to its previous level. 
Three intramuscular injections each of ten mg. vitamin B^ 
at twelve-hourly intervals before the insulin, had a similar 
intensifying effect. An intravenous injection of twenty mg. 
aneurin given simultaneously with an oral dose of glucose 
caused a distinctly greater rise of the blood-sugar level 
in six out of seven subjects for a period of lj hours after 
the dose; two hours after the dose the blood-sugar values
were the same, whether the vitamin had been given or not.
These experiments, the author suggested, indicated that 
vitamin Bq not only intensified the action of insulin, but 
also hastened the absorption of sugar.
Kodicek studied the effect of aneurin oh the blood-sugar 
of 32 diabetics. The vitamin, either alone or in combination 
with insulin, did not affect the fasting blood-sugar of the 
patients nor increase the action of insulin. He gave ten 
mg. aneurin daily for four weeks to two diabetics with no ' 
improvement in their sugar tolerance or insulin requirement, 
.mile agreeing that a partial deficiency of vitamin is 
lively to be an incidental accompaniment of diabetes, he 
could not confirm that the use of aneurin to increase the 
sugar tolerance in diabetics was justified.
Six diabetics, previously stabilised on a constant 
diet with a constant dose of insulin, were studied by Dienst. 
They were given orally 240 units of vitamin B^ per day 
in a proprietary preparation containing the vitamin B complex, 
and vitamin 0. The carbohydrate tolerance of every patient 
was improved to a degree corresponding with the effect of 
ten to twenty units of insulin a day. Smaller doses of the 
preparation had no effect. Fluctuations of the blood-sugar 
level were reduced, and the frequent severe hypoglycaemic 
reactions in two patients disappeared when the extra vitamins 
were given.
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Sendrail and Mareeillac gave both vitamin and C to 
ten diabetic cases. They concluded that ascorbic acid exerted 
a more rapid action than vitamin B^ on the sensitivity of 
the individual to insulin. The two vitamins together seemed 
to reduce the glycosuria before the blood-sugars fell, as 
if the renal threshold for glucose had been raised.
Vorhaus et al. claimed "an increased utilisation of 
carbohydrates'’ in six out of eleven diabetics who were given 
orally ten mg. vitamin B1 daily for four weeks. The facts 
that many of the patients lost weight and that their diets 
were changed during the experimental period made this in­
vestigation of little value. /
A later report by Vorhaus admitted that the majority 
of diabetics did not benefit from aneurin administration.
Only in those who showed some signs of deficiency was the 
vitamin of value.
In a series of ten well-controlled cases, three mg. 
daily of aneurin in addition to that received in the food 
had no significant effect on the blood-sugar of diabetics 
(Kaufman). He concluded that this vitamin was not indicated 
as a routine measure for diabetics.
Smith and Mason kept two severe diabetics on vitamin 
deficient diets. A third was given injections of glucose, 
with and without the addition of vitamin B^. They were unable 
to find that aneurin had any effect on the intensity of
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diabetes, or on the sensitivity of diabetics to the action 
of insulin.
Sciclounoff gave vitamin B-^  orally and parenterally 
to 35 diabetics. Twelve showed improvement of symptoms 
lasting for periods of several days up to Eome months.
The rise in blood-sugar following glucose injections was 
stated to be less marked after the vitamin's administration.
He believed that aneurin was at least a useful addition in 
the treatment of diabetic acidosis.
Williams et al. studied four subjects on a low aneurin 
diet for a prolonged period. In three, the blood-sugar tol­
erance curves reached diabetic levels. The curves returned to 
normal after administration of the vitamin. They had pre­
viously reported the same findings on four other subjects.
Bueding et al. gave similar findings. The average blood- 
sugar curve following glucose ingestion by fifteen aneurin- 
deficient subjects was significantly higher and more prolonged 
than that of 23 controls. In most, the blood-sugar level 
rose above the renal threshold.
Trasoff and Bordin found improved carbohydrate tolerance 
in five out of fifteen diabetics receiving 2 to 10 mg. 
vitamin B^ daily. A careful analysis showed that the improve­
ment could not be attributed, however, to the vitamin 
therapy. Similar results were reported by Costa and Mosuello.
Hoeonyl and Aszodi claimed that the injection of five
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mg. aneurin into diabetics produced an initial hyperglycaemia 
followed by a protracted fall in the blood-sugar level.
The initial hyperglycaemia was abolished by the simultaneous 
administration of 300 mg. vitamin C. They gave seven moderate 
diabetics 300 to 2,000 mg. vitamin C and one to ten mg. 
vitamin daily. Daily blood and urinary sugartvalues were 
determined. It was found that the maintenance dose of 
insulin could be reduced after a few days. Sometimes the 
patient was able to keep the urine sugar-free without insulin 
for several weeks. Due to the variable dosage and poor control 
of their patients, however, their conclusions were not 
convincing.
Wilder believes that the diabetic probably requires 
more vitamin B^ than is easily obtained in a mixed diet.
He considers that additional doses of aneurin and riboflavin 
are of little value, except in cases with a previously 
deficient intake of these vitamins.
Von Drigalsxi also believed that the results of experi­
ments on animals with B-avitaminosis could not be applied 
to human diabetes. After a poorly controlled investigation 
of ten diabetics, he believed that aneurin had no influence 
on the glycosuria, blood-sugar levels or insulin requirement.
To summarise these findings, one might say that although 
many reports have suggested that aneurin lowered the blood- 
sugar levels of diabetics and rendered them more sensitive
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to insulin, numerous other papers have failed to confirm 
this. Treatment of diabetics with aneurin, therefore, will 
probably never be of any great practical value.
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RIBOFLAVIN AND BLOOD-SUGAR LEVELS.
Sine© n© important investigations have heen published 
on the effect of riboflavin alone on diabetics, and since 
theoretically it seemed the least likely to be of any value, 
the blood-sugar curves were carried out only on four non­
diabetic patients. Two received ten mg. and two received 
twenty mg. riboflavin intravenously.
The results given in Table VII indicate that riboflavin 
has no significant effect on the blood-sugar levels of non­
diabetic patients. Graphs of the blood-sugar curves follow 
the table.
Table VII
Blood-Sugar Concentration Mg.%
Standard
Deviation
Patient’s 
Initials.
Time
0
in Hours After 
Commenced
i i _
Investigation/Mean 
2 3
N.L. 148 131 138 138 132 137 6.8
J • i- . 82 92 90 90 88.5 88 3.9
J.B. 86 81 77 80 82 81 3.3
D.M. 86 83 90 98 96 91 6.4
Average Standard Deviation 5.1
;u+ ho
B.jj.,aged 61, had a cerebral embolism from which he died
two days later.
lo
J.*., aged 24, had a large pleural effusion of indefinite 
causation.
J.B.,aged 51, had a large syphilitic aortic aneurysm.
Xo
■t—f-
<3^ M OM3 a_|rix
Dm A .,aged 62, was a case of congestive heart failure 
secondary to hypertension.
a brief summary of the pharmacology of riboflavin might 
now suitably be given.
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PHARMACOLOGY OF RIBOF1AVIB.
Riboflavin is a fine, orange-yellow crystalline powder 
which has the structural formula;
i
H H H
0 0 0
c - c - C
H H H
H
G C = 0
i I
C NH
Y v™ n
It iB only slightly soluble in water, and in solution 
is destroyed rapidly by light.
It is absorbed by phosphorylation from the small intestine 
Absorption is impaired with gastro-intestinal lesions such 
as peptic ulcer or carcinoma, and where there is much vomiting 
or continued diarrhoea.
Riboflavin is excreted in the urine and sweat, and is 
destroyed in the large bowel. It is probably also synthesized 
to some extent in the human intestine.
About 2.5 to 3 mg. daily is a liberal allowance for 
a normal adult. Its requirement is increased by exercise, 
pregnancy, lactation, and a high fat diet, hyperthyroidism, 
fever and diabetes mellitus are pathological conditions 
which increase the requirement.
Riboflavin combines with phosphoric acid, a specific 
protein and ribose to form the !1yellow enzyme11 as well as 
at least eight other coenzymes. Ihese riboflavin enzymes
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are dehydrogenases, which remove hydrogen from the nicotinic 
acid enzymes (coenzymes I and II). Using the cytochrome 
system, the hydrogen ions then combine with molecular oxygen 
to form water. The riboflavin enzymes thus take part in 
the carbohydrate metabolism, acting as coenzymes in the 
transference of hydrogen.
The stages in this process can be briefly stated as 
follows:
(1) CARBOHYDRATE SUBSTRATE * NICOTINIC ACID ENZYME oxidation ^  
OXIDISED SUBSTRATE + REDUCED NICOTINIC ACID ENZYME.
(2) REDUCED NICOTINIC ACID ENZYME + FLAVOPROTEIN dehydrogenation
(riboflavin enzyme) ^
NICOTINIC ACID ENZYME ■+ REDUCED FLAVOPROTEIN.
(3) REDUCED FLAVOPROTEIN * CYTOCHROME SYSTEM f MOLECULAR
OXYGEN'
FLAVOPROTEIN v rfATER. ^
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NICOTINAMIDE AND BLOOD-SUGAR LEVELS
NICOTINAMIDE AND BLOOD-SUGAR LEVELS
Nicotinamide was given intravenously in doses of fifty 
to 100 mg. to eighteen non-diahetic and six diabetic patients. 
The results are shown in Tables VIII and IX respectively.
The average standard deviation suggests that nicotinamide 
has no significant effect on the fasting blood-sugar levels 
of diabetic and non-diabetic persons. The graphs of these 
patients follow the respective tables.
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Table VIII
Patient *s 
Initials.
Blood-Sugar Concentration M&.i 
Time in Hours alter Investigation 
Commenced.
....... 0. k.... 1...  2 ....3 .....
Mean Standard 
Deviation
R.K. Ill 124 123 124 129 124 8.6
3 • 93 92 96 93 98 94 2.4
P.O. 94 100 98 106 103 101 4.7
G.M. 82 88.5 89.5 102 106 93 10.0
W.T. 102 106 105 98 80 98 10.6
J.D. 92 98 89 95.5 96 94 3.6
A.P. 68 68 60 65.5 68 66 3.5
J.M. 84 90 90 91 88 69 2.8
L.B. 96 101 100 102 106 101 3.6
A.H. 93 97 100 105 100 99 4.4
J.JP. 101 119 118 109 119-... 113 8.0
112 104 -112 112 116 111 4.4
A.L. 96 92.. 100 93.__ 1Q4 .... 97 _ 3 • 8
HaA • 84 82 81 86 88 84 .. 2.9
96 100 104 . 102 100 100 __3
D*I>. 93 80 82 .89.. 94 88 6.4
w*e* 109 110 105 106 105 105 3.2
A.ASL 96 100 101 102 100 100 2.3
Average Stsndard Deviation — Is 9..
io
U.K.,aged 31, had symptoms of a duodenal ulcer for six years.
S.M.,aged 41, had a mild acute nephritis for one month.
106
tf.C.,aged 38, had an acute rheumatism of three weeks1 duration
4k
<?0
Gr.M., aged 51, had symptoms of a mild coronary thrombosis.
JUl
SO
vtf.T.,aged 4t>, was a mild encephalitis case of unknown etiology.
IOO •
'BXcmJ-
•*>%
<? O
J.D..aged 34, had a right idiopathic sciatica for nine weeks
t>0
A.D.,aged 50, had a mild steatorrhoea following a partial
gastrectomy.
—
loo •
- __
1 *
h
k/Y**O 'MJ'-L 1i; k.. Sk 1H L 30 W Jr u •*c JkC
- — -
~
<\ o •
&0
D i 1 3L M ovO irtXAwvwv c^ UjS-w 3
  ;    ------
J.M. ,aged 53, had a rheumatoid arthritis for years.
I OO
L.3.,aged 30, had a diarrhoea of uncertain etiology
lOOvw^. n wV w\ft
I 3*0 -
TUo«l'
A.H., aged 39, was a case of gastric neurosis.
J .D.,aged 25, had a duodenal ulcer.
HjuL.mux. ’-X d Uwvrvivi>-
I I .L., aged 64, was a ease of myocardial degeneration.
^.L.,aged 26, had a benign lymphocytic meningitis.
IT
.. i-■ ■
K. A., aged 28, had a duodenal ulcer and haematemesie.
XLC. (» . IO O vwj . l i ’XgT^O/twJkfa-
P.C.,aged 33, was quite normal
lOjo*ju/» l60g*g. lluiUvOwJk
H tnsCS a|&l ui£an*J>~>. cjwt**.
D.L.,aged 48, had a deep gastric ulcer.
S' d U u x tti^ a iM c L
Hrvmr>a|5o wtj&’wiUA. njt+.-Vv%
W. C., aged 35, had a large pleural effusion.
!fO - -r
tStootl- (LwoVko ^  OowxtA 
Su^ J
lH*%
A.M.,aged 50, had a paroxysmal tachycardia .
Table IX.
Patient1s 
Initials.
Blood-Sugar Concentration M^.% 
Time in Hours After Investigation 
Commenced.
0 4 1 2  3
Mean Standard
Deviation
F.E. 261 263 280 284 289 275 12.7
C. H • 232 238 258 245 240 243 9.8
s.c. 141 149 136 121 120 133 12.7
M.B. 192 200 197 196 210 199 6.9
C • B • 140 148 155 144 152 148 6.0
K.W. 300 299 296 286 272 291 12.0
Average Standard Deviation 10.0
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So
F.H.,aged 35, was taking 30 units S.I. and 15 units P.5.I. 
daily lor his diabetes of five years' duration.
CfaXkxr^vvt kS
J-7,o
C.w.,aged 67, had not yet been started on insulin for her 
glycosuria of nine weeds' duration.
S.C.,aged 66, shows an interesting hut not statistically 
significant fall in her hlood-sugar level.
hlq^ vj J5(yfttru4
H.B.,eged 71, was treated hy diet for her glycosuria of 
sixteen years1 duration.
lU'CffCl’VCUWttjU.
"j” 5
C.B.,aged 50, was a newly-discovered diabetic
I(bO-
IIuj?<^vkuU'
K -M aced 25 shows an interesting fall in his blood-sugar 
a.w., aged 25, s. -H-naatinp the estimations. He had been
level confirmed by ^ere filrlywell controlled on a a diabetic for four /ears, i i y 8 p>z>;[>
sixteen line diet with 30 univs o.x.
daily.
an.
PHABMACOLOGrY OF HICOTIKAMXIJ©.
PHARMACOLOGY OF H ICO TIN AMIDE.
A short summary of the pharmacology of nicotinamide 
will now he given.
nicotinamide, also called nicotinic acid amide and 
niacin, is a stable white substance with the structural 
formula;
It is probably synthesized to some extent in the human 
intestine. It is excreted in the urine and sweat.
nicotinamide combines with adenine, ribose and phos­
phoric acid to form two coenzymes named coenzyme I (also 
called eodehydrogenase I or cozymase) with two phosphoric 
acid molecules, and eoenzyme II (also named codehydrogen- 
•ee II) with three phosphoric acid molecules.
These eoenzymes catalyse the dehydrogenation of various 
carbohydrate substrates by absorbing two atoms of hydrogen. 
The hydrogen atoms are handed on to the riboflavin enzymes, 
which combine the hydrogen with oxygen to form water. The 
eoenzymes are also involved in phosphorylation and pyruvic
*cid oxidation.
The present beliefs about the action of nicotinamide
may therefore be summarised as follows. Coenzyme I or
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diphosphopyridine nucleotide, and coenzyme II or triphospho- 
pyridine nucleotide both contain nicotinamide. Both of these 
coenzymes act with a large number of apoenzymes, which 
include the riboflavin enzymes described previously. Each 
apoenzyme acts on a specific carbohydrate substrate, and 
each substrate has its own dehydrogenase.
Reduction or hydrogenation of the coenzymes occurs when 
they accept two atoms of hydrogen from the carbohydrate 
substrate. Dehydrogenation then follows, when the hydrogen 
atoms are passed on to other hydrogen acceptors, which may 
be the riboflavin enzymes or other metabolites. The eoenzymes 
therefore, simply act as intermediaries in the transference 
of hydrogen from one compound to another.
The processes in this stage of carbohydrate metabolism 
can be even more briefly shown as follows;
(1) SUBSTRATE + COEITZYME . OXIDISED SUBSTRATE +
------- * REDUCED COENZYME.
(2) REDUCED COENZYME + FLAVOPROTEIN ____>
COENZYME 4 REDUCED FLAVOPROTEIN.
(3) REDUCED FLAVOPROTEIN 4 CYTOCHROME SYSTEM 4 MOLECULAR ^
FLAVOPROTEIN + x/ATER.
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NICOTINAMIDE AMD THE BLOOD-SUGAB LEVELS OF ANIMALS.
NICOTINAMIDE AND TEE BLOOD-SUGAR LEVELS OF ANIMALS 
Greco injected nicotinic acid intravenously into 
fasting dogs. Small doses increased the blood-sugar level, 
but the rise was less marked with large doses.
A mild hypoglyeaemic effect of nicotinic acid on 
various animals was reported hy Boldyreff, the hypoglyeaemic 
action being most marked in turtles.
Burke and McIntyre found that nicotinic acid decreased 
markedly the duration of hypoglycaemia in rats following 
the injection of a standard dose of insulin.
That the intravenous injection of nicotinic acid pre­
vented the diabetogenic action of alloxan in five rabbits 
and six rats, was reported by Banerjee. He thought it 
possible that nicotinic acid might play some part:iin the 
prevention of diabetes. This was based on the suggestion of 
Dunn et al. that possible defects in the metabolism of 
purines or of alloxan in man might play some role in the 
etiology of diabetes. Sufficient nicotinic acid in the diet 
oiight prevent the action of alloxan.
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HICOTIMAMIDE IM MOBMAL AMD DIABETIC PEBSOMS.
Once again the results of the different investigators 
are confusing.
Crino and Lenzi found that injections of nicotinamide 
temporarily increased the hlood-sugar in normal people and 
diabetics.
Subcutaneous insulin had a more pronounced and prolonged 
effect in pellagrins than in normal subjects (Mainzer). The 
administration of glucose to pellagrins produced blood- 
sugar values similar to those produced in normal subjects.
The papers of Sydenstricker et al.,and of Vilter et al. 
indicate that nicotinamide deficiency is often present in 
diabetics with ketosis or other complications.
The results of Meuwahl published in 1943 are startlingly 
different from those of many other reliable investigators.
The intramuscular and intravenous injection of nicotinamide 
caused a marked fall in the fasting blood-sugar of nine 
healthy adults. The venous blood-sugar fell much more than 
the arterial blood-sugar. He considered that this indicated 
that the activity of endogenous insulin had been increased 
by the nicotinamide.' The vitamin greatly increased the res­
ponse of three non-diabetic patients to two units of insulin. 
Larger intravenous doses of nicotinamide caused intense 
hyperglycaemia without glycosuria in three fasting healthy 
subjects. The carbohydrate tolerance of twelve elderly
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^■i®hetics improved with nicotinamide therapy. Hg dGscribos 
three of tliGSG eases in whom the improvement was remarkable.
iurther communications by Ifeuwahl in 1947 are less 
enthusiastic. The theories which he puts forward on the 
subject are not impressive. One does not feel that the 
results of this investigator can be taken too seriously.
•/.Gordon reported enthusiastically on one mild diabetic 
who improved considerably on large oral doses of nicotinamide. 
He believed that the nicotinamide increased the activity 
of those islets of Langerhans which were still functioning, 
but made the rather ambiguous statement that the greater 
insulin production may not affect the glucose tolerance curve.
1.Gordon described the beneficial effect of nicotin­
amide on one diabetic and a case of renal glycosuria.
In a paper describing the treatment of thirty diabetics 
with oral nicotinamide in large doses, Talaat agreed with 
Gordon that the vitamin could replace insulin in the treat­
ment of mild elderly diabetics, nicotinamide enabled a 
reduction in insulin dosage to be made in more severe cases.
y/adc reported no improvement in six mild diabetics who 
were given large oral doses of nicotinamide for a fortnight.
He concluded that nicotinamide alone does not influence the 
sugar tolerance or improve the diabetic condition. This con­
clusion could have been given more weight if the number of 
subjects had been larger and the time of investigation longer.
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A short report by Cumings showed that nicotinamide had 
no effect on the fasting blood-s&gar level or blood ceenzyme 
content of three normal subjects. The opinion is thus 
becoming more generalised that nicotinamide can have no 
beneficial effect on most diabetics.
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THE SIMULTANEOUS ADMINISTRATION OF
ANEURIN, RIBOFLAVIN AND NICOTINAMIDE
Since the three Titamins separately had been shown to 
have no definite effect on blood-sugar levels, it remained 
to be seen whether the three together produced any change. 
This was carried out on fourteen non-diabetic patients and 
three diabetics, who were each given 25 mg. aneurin, ten mg. 
riboflavin and 50 mg. nicotinamide intravenously. The results 
are given in Tables X and XI respectively. These indicate 
that aneurin, riboflavin and nicotinamide administered 
simultaneously have no significant effect on the fasting 
blood-sugar levels of diabetic and non-diabetic persons.
Table X
Patient * s 
Initials
Tirae
0
in 1 ours after Inve 
Commenced•
..- i 1 2
sti^a
?
tion Mean Standard
Deviation
A.M. 118 119 104 101 114 111 8.2
A.B. 106 115 116 93 92 104 11.6
J.A. 90 96 96 82 81 89 7.3
w.c. 82 87 96 87 86 88 5.0
R.M. 81 86 92 82 83 85 4,4
G.H. 82 87 104 100 106 96 10.7
h .m . 58 60 66 60 63 61 3,2
I.P. 70 62 61 78 83 71 9,7
J,M, 81 84 94 99 95 91 7.7
Gr,A • 100 96 88 80 79 89 9,4
D.B. 129 136 124 128 121 128 5.7
J.F, 96 87 86 90 88 89 4,0
i.e. 75 89 73 71 72 76
A.C. 97 104 108 98 91 100 6.6
Average Standard Deviation. Z.f.2.
I3lo r
QS>J/X. . .
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w^. Rjnr^l .*♦ SOwj. fUo*t. 
3.s|«|^ 8.
B.,aged 62, had a cerebral thrombosis and right hemiplegia.
it Mou^r> &|a4 gUa>v\ . 3
J.A.,aged 49, had a tuberculous spine.
<i/.C.,aged 46, had a bronchogenic carcinoma with spread 
to the cervical glands.
5*-5" ^ (Ow\^ , ■'^ Jdvj R w ^ v' -
50
K.M., aged 58, was a case of asprin poisoning.
HO
'gujd- H v\fcotpv\«
Swyw
60
G.E.,aged 57, had a severe haamatemeBie from a peptic ulcer.
10 - 
Btodl- Hix^ k. L.
71 05^3 + |c* RJU{1.-rTOr9. Hlo&'v*,s
*5%
•f‘ j"
i
So
c
4— »
+—
jUX
H—
( £l Htrvwio^ 1UlJLlgVv&r. /
h.M.,aged 49, was recovering from a eubarachnoid haemorrhage.
9 0 ~r 
Sxcpj (MS. 4 10 (2tlrti|€ .+ S“d Yluodtvtfv .
to
HcJVO kv&wwu qutM
E.F.,aged 47, had a severe congestive heart failure due 
to hypertension.
loo - •
‘fowl- c^ftnrv fVliSCcvrVw
5 ^  0 —
*al
Moh^o «|tvc ifduj'tAv** cjur€w..
J.M.,aged 51, had a chronic bronchitis.
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G.A., aged 36, had a pulmonary abscess.
lW«Xw>
9L H <AW» oijlA trvdv^tOM cjl*rt«\
D.B.,aged 46, had a pneumonia with neurasthenia.
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<juX~T*
J.F.,aged 58, had a tabes dorsalie.
A- MowO a|l>j cyjLS&j .
■2.0., aged 49, had a pulmonary tuberculosis.
hvtj iOvy^  . 50v«^ . Hvjuilvvv
!£~ -
Mfl\vrs °l|^* ^ AvM'i^Urtw ,
A.C.,aged 59, had a deep gastric ulcer.
3,5
A.M.,aged 62, had a carcinoma ol lung with cerebralwith ce
secondaries.
Table XI
Patient’s 
Initials
Blood-Sugar Concentration Mg.% 
Time in Hours After Investigation 
Commenced 
0 i 1 2 3
Mean Standard
Deviation
E.D. 211 222 228 212 216 218 7.2
J.M. 166 151 149 146 160 155 9.1
E.G. 179 172 174 155 152 166 12.1
Average Standard Deviation 9.5
auiw
S.a.,aged 59, was an obese woman who had not been on insulin 
for her glycosuria.
A^jvLvrr^ a. OowysJQulKiJL
JL 'H O W W  ei|& «vtd*rtVvyi
H<*W» O^ *4 \J*SH^>rrMkc
3.D.,aged 66, had had glycosuria for two years, but had 
not been on insulin.
J.Mi, aged 46, did not require ineulin for hie mild glycoeurie.
■tUO
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THE VITAMIN B COMPLEX AND ANIMALS.
Collip (quoted by Gaebler), in 1925 postulated the 
existence in plants of an insulin-like hormone, which he 
called glucokenin. This lowered the blood-sugar level of 
normal and of depancreatized dogs.
Martin administered insulin to depancreatized dogs on 
diets free from vitamin B-j_ and riboflavin. The animals still 
suffered from hyperglycaemia and glycosuria. The admin­
istration of aneurin alone produced no improvement. When 
given with riboflavin, however, the action of the insulin was 
so increased that hypoglycaemic shock was produced. He noted 
that choline was of no great anti-diabetic efficacy. The 
action of insulin, he concluded, apparently depended on the 
presence of factors comprising the vitamin B complex.
Gaebler and Ciszewski withdrew the yeast from the diet 
of three depancreatized dogs whose glycosuria was adequately 
controlled with a constant amount of food and insulin. The 
glycosuria returned in two of the animals. They then tried 
to produce the beneficial effects of yeast with known 
vitamins. Inositol, they found, appeared to be one of the 
active constituents which prevented the glycosuria. The 
administration of seven of the known constituents of yeast 
produced the same beneficial effects. These constituents were 
aneurin, riboflavin, nicotinic acid, inositol, pyridoxin, 
pantothenic acid and para-aminobenxoic acid. One of the three
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dogs did not show any relationship between the vitamin B 
intake and its insulin requirement. The glycosuria of another 
of the animals could be controlled by increasing the dose 
of insulin by 50%. This suggested that the yeast had enabled 
the insulin dosage to be decreased by one-third.
Further experiments were carried out by Gaebler and 
Mathies on the same depancreatized dogs made deficient of the 
water-soluble vitamins, v/hen the food intake and insulin dosage 
remained constant, the control of the glycosuria was regained 
when aneurin, riboflavin, nicotinic acid, pyridoxin and 
pantothenic acid were added to the diet. Pyridoxin and 
pantothenic acid, separately and together, diminished the 
glycosuria in experiments in which they were the only 
variables. Once again the same depancreatized dog showed no 
response when the vitamins were added or withdrawn.
These reports all tended to support the view that 
the vitamin B complex might have a beneficial effect in 
diabetes mellitus.
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THE VITAMIN B COMPLEX AND DIABETES MELLITUS.
Once again the mixture of favourable and unfavourable 
reports makes the issue far from clear.
In 1923, Desgrez stated that the addition of vitamin B 
to the diet of diabetic patients prolonged and increased the 
effect of insulin. Owens et al.,however, administered large 
amounts of aneurin and riboflavin to well-controlled 
diabetics for many weeks. They failed to observe any reduction 
in the insulin requirement or any alteration in the severity 
of the disease. Many of the claims of benefit from vitamin 
therapy, they believed, were based on investigations carried 
out before the disease had been brought under proper control. 
They did find, however, that aneurin therapy caused rapid 
improvement in diabetic neuritis.
The reports of Jackson and Barth, and of Hobson et al. 
were also unfavourable, the former working on diabetic chil­
dren and the latter on adults. The vitamin B complex had no 
effect on the insulin dosage or the severity of the diabetes.
Rudy and Hoffmann believed that many of the skin com­
plications of diabetics were manifestations of vitamin B 
complex deficiency, especially of nicotinamide, while 
describing the successful clearing up of these lesions with 
vitamin therapy, they made no mention of any improvement in 
the diabetic condition.
Biskind and Schreirer, on the other hand, studied 94
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diabetics, who they claimed all showed signs and symptoms 
of deficiency bf factors of the B complex, intensive and 
persistent therapy with the vitamin B complex improved their 
general health and often reduced and even eliminated the 
insulin dosage. They suggested that protracted vitamin B 
complex deficiency caused impaired hepatic response to 
endogenous insulin, which they believed was the condition 
present in the vast majority of diabetics.
Also more optimistic was the report of Parr and Shipton 
on the beneficial effects of yeast in diabetes mellitus. 
Brief, though not altogether convincing reports were given 
on five of their cases which they believed showed consider­
able functional recovery in some of the cells of the islets 
©f Langerhans. (The authors suggested, incidentally, that 
an increased incidence of diabetes mellitus may result from 
a deficiency bf the vitamin B complex in the modern 
civilised diet).
Trasoff and Bordin found thatvthe carbohydrate toler­
ance of five out of 15 diabetics on vitamin B therapy was 
improved, oareful analysis failed to show that the improve­
ment was due to the vitamin therapy. They suggested that the 
favourable reports of others may be due only to the treat­
ment of unrecognised, subelinieal avitaminoses, or to the 
removal of infection or increase in the carbohydrate ratio.
Before concluding, it would not be entirely irrelevant
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to summarise shortly reports on the aneurin therapy of 
diabetic neuritis.
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VITAMIN Bx AND DIABETIC NEURITIS.
The peripheral neuropathy of diabetic patients was first 
described by Marchal de Calvi in 1864. tfohl in 1926 first 
suggested that vitamin B deficiency might be an etifological 
factor, due to the results of treatment with yedst and yeast 
concentrated. His article gave a fairly full clinical and 
pathological description of a fatal case of diabetes with 
neuritis and other signs of multiple vitamin deficiencies. 
Dietetic, vitamin and insulin therapy had produced slow 
but steady improvement, until the patient's mother stopped 
the insulin and death resulted.
The next few years saw favourable reports by Angle,
Minot, wechsler, and Hoot and Hogers on the beneficial effects 
on the neuropathy of a high vitamin intake. Vorhaus et al., 
and Sciclounoff and Broccard soon suggested on therapeutic 
grounds that vitamin B^ deficiency was the main causal 
factor in diabetic neuritis.
A letter from Lawrence and Oakley described their ex­
perience of the administration of large doses of aneurin to 
diabetics, while the neuritis was often benefited, there was 
no change in the carbohydrate tolerance or insulin requirement.
Needles found that the aneurin intake of three diabetics 
with peripneral neuritis was quite adequate. He therefore
believed it unlikely tnat vitamin B deficiency was the cause
1
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of the neuritis. The absorption, utilisation and excretion 
of the vitamin would have had to be studied in the diabetics, 
however, before any definite conclusion could be drawn.
In a careful and well tabulated investigation, Fein et 
al. state that the type of diabetic neuritis due to vitamin 
deficiency is a "symmetrical peripheral neuropathy begin­
ning first in, and involving primarily, the lower extremities.” 
The daily administration of ten mg. aneurin hydrochloride by 
mouth to nine such patients, without any other change in the 
regimen, resulted in the cure of eight subjects and objec­
tive improvement in the ninth. The other types of neuritis 
in diabetes, involving single nerves or producing vague aches 
and pains, showed no definite improvement on aneurin therapy.
A further paper by Needles in 1943 quite contradicted 
these findings. Seven esses of diabetic neuritis failed to 
show any objective improvement on aneurin therapy; indeed, 
two of the cases became worse during the treatment.
Hoot and Bailey commented in 1945: "Though immediate 
improvement with thiamine is rarely observed in cases of 
diabetic neuritis, the majority of such cases under such 
therapy show gradual improvement over a period of several 
months, provided the cases are brought under good diabetic 
control."
^n unfavourable report came from Broch and Hlonstad in 
1947. Sixty diabetics with polyneuritis were given vitamin
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B-^  and 36.5% were cured or distinctly improved. 16^ of the 
28 patients receiving no therapy showed similar improvement. 
In those who benefited, they suggest, improvement was not so 
immediate as it would be if an aneurin deficiency existed. 
They concluded, therefore, that their investigations fur­
nished no support for the belief that deficiency caused 
diabetic polyneuritis. They believed that a circulatory 
disturbance was the more likely cause.
In an extensive review of the literature with a report 
of 125 cases, Bundles also agreed that aneurin deficiency 
was an unlikely cause, and considered that treatment with 
the vitamin was unsatisfactory.
Opinions are therefore now veering round to the view 
that the neurological complications of diabetes are not 
the result of vitamin deficiency, and will not respond well 
to vitamin therapy.
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SUMMARY AND CONCLUSIONS.
In the writer's own investigations, aneurin, riboflavin 
and nicotinamide were administered separately and together 
to diabetic and non-diabetic patients. No significant 
changes occurred in the blood-sugar levelE during the three 
hours following administration.
Many of the previous, more favourable reports were 
based on inadequately controlled experiments with too small 
numbers of cases. In some reports, the accuracy of the 
biochemical work was questionable.
The ciain drawback of the present investigations is that 
the number of diabetics tested is still too small, precau­
tions were taken to verify any marked changes in the blood- 
sugar levels, to exclude the possibility that they were 
due to inaccuracies in the biochemical estimations.
It is now becoming fairly clear that while various 
factors in the vitamin B complex play important parts in 
the metabolism of carbohydrates, it is not likely that 
any of them could tame the place of, or increase the effect 
of insulin. There is also no definite evidence that an 
increased need of the vitamins exists in uncomplicated 
diabetes. Vitamin B therapy is therefore not necessary in 
the routine treatment of diabetes.
But it is also now becoming more generally recognised
117.
that vitamin B supplements are useful in many complications 
of diabetes, such as infections, parenteral feeding and old 
age. Opinions are now more prevalent that very few, if any, 
cases of diabetic neuritis are due to aneurin deficiency.
In the absence of any other definite cause, however, it seems 
that intensive and prolonged aneurin therapy is still worthy 
of trial in diabetic neuritis.
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